The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.
IL-27 在维持耗尽的 CD8 T 细胞对持续感染和癌症的反应中的作用。
基本信息
- 批准号:10650747
- 负责人:
- 金额:$ 54.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-06 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAnimal ModelAntigensAntitumor ResponseApoptosisApoptoticBLR1 geneBiochemicalBiological Response ModifiersBiologyCD8-Positive T-LymphocytesCancer ModelCancer PatientCell DeathCell SurvivalCell divisionCell physiologyCellsChronicCoupledCytoprotectionDiseaseDivingEndowmentGeneticGoalsHIV/HCVIFNAR1 geneIRF1 geneImmuneImmunotherapyInfectionInterferonsKnowledgeLoxP-flanked alleleLymphocytic choriomeningitis virusMalignant NeoplasmsMemoryMethodsModalityModelingMolecularMusPatientsPopulationProcessProductionProliferatingProteomicsPublishingReporterReportingResistance developmentRoleSignal InductionSignal PathwaySignal TransductionSourceSurfaceT cell differentiationT cell responseT-LymphocyteTCF Transcription FactorTestingViralViral CancerVirusVirus DiseasesWorkanti-PD-1anti-PD-1/PD-L1anti-PD-L1 therapyanti-PD1 therapyantigen-specific T cellscancer therapychronic infectioncytokinedisorder controlexhaustexhaustionimmune checkpoint blockadeimprovedinflammatory milieupreventprogrammed cell death protein 1receptorresponseself-renewalstemtranscription factortumor
项目摘要
Project Summary
Chronic infection and cancer are associated with suppressed T cell responses resulting in the inability to control
these diseases. Over the last 15 years, blockade of negative immune regulators has proven effective in a small
number of cancer patients and shown promise in animal models of chronic viral infection. Despite these
encouraging results, no effective immune therapies exist for chronic viral infection and most patients fail to
respond or develop resistance to checkpoint blockade. Recent work identified memory-like CXCR5+ TCF1+ CD8+
T cells which sustain T cell responses during persistent infection and cancer. Importantly, these cells generate
the major proliferative burst observed following anti-PD1 treatment. Further, the numbers of TCF1+ CD8 T cells
in tumors correlate with favorable responses to anti-PD-1 treatment. As such, approaches to expand these cells
are actively sought.
We recently reported that blockade of interferon type 1 (IFN-I) receptor leads to expansion of CXCR5+
CD8+ T cells in an IL-27-dependent manner. IFNAR1 blockade promoted accelerated cell division and retention
of TCF1 in virus-specific exhausted CD8+ T cells. We found that CD8+ T cell-intrinsic IL-27 signaling promotes
the TCF1-high cells to maintain proliferation and avoid programmed cell death. Mechanistically, IL-27 endowed
rapidly dividing cells with IRF1, a transcription factor that was required for sustained division in a cell-intrinsic
manner. These findings revealed that IL-27 is essential for the expansion of TCF1+ CD8 T cells following
persistent viral infection. We hypothesize that IL-27 produced by specific cell subsets is necessary to
safeguard rapidly diving CD8 T cells from apoptotic cell death during both persistent viral infection and
cancer. We propose in this application to explore the basic biology of IL-27 signaling as it relates to CD8 T cell
expansion, survival and function. We will assess the cellular populations and signals that induce IL-27
production, assess how IL-27 prevents apoptosis of rapidly diving TCF1+ CD8 T cells and expand our exploration
into whether IL-27 signaling following anti-PD-1/L1 treatment during persistent LCMV infection and syngeneic
tumors is crucial for the CD8 T cell expansion/function. Once completed these studies will provide important
basic knowledge of how IL-27 regulates anti-viral and anti-tumor responses. Moreover, findings from this study
should point the way to treatments and modalities that can be employed to sustain optimal T cells responses.
项目摘要
慢性感染和癌症与抑制T细胞反应有关,导致无法控制
这些疾病。在过去的15年里,阻断负性免疫调节因子已被证明在小范围内有效。
癌症患者的数量,并在慢性病毒感染的动物模型中显示出希望。尽管有这些
令人鼓舞的结果,没有有效的免疫疗法存在慢性病毒感染,大多数患者未能
对检查站封锁作出反应或产生抵抗。最近的工作确定了记忆样CXCR 5 + TCF 1 + CD 8 +
在持续感染和癌症期间维持T细胞应答的T细胞。重要的是,这些细胞产生
抗PD 1治疗后观察到的主要增殖爆发。此外,TCF 1 + CD 8 T细胞的数量
与抗PD-1治疗的有利反应相关。因此,扩增这些细胞的方法
积极寻求。
我们最近报道,阻断干扰素1型(IFN-I)受体导致CXCR 5+细胞扩增,
CD 8 + T细胞以IL-27依赖性方式表达。IFNAR 1阻断促进加速细胞分裂和保留
TCF 1在病毒特异性耗尽的CD 8 + T细胞中的表达。我们发现,CD 8 + T细胞内在IL-27信号转导促进
TCF 1-高细胞维持增殖并避免程序性细胞死亡。从机制上讲,IL-27赋予了
快速分裂的细胞与IRF 1,一种转录因子,需要在细胞内持续分裂,
方式这些发现揭示了IL-27对于TCF 1 + CD 8 T细胞的扩增是必需的,
持续性病毒感染我们假设特定细胞亚群产生的IL-27是
在持续性病毒感染期间,
癌在本申请中,我们提出探索IL-27信号传导的基础生物学,因为它涉及CD 8 T细胞
扩张、生存和功能。我们将评估诱导IL-27的细胞群体和信号
生产,评估IL-27如何防止快速潜水TCF 1 + CD 8 T细胞凋亡,并扩大我们的探索
在持续性LCMV感染和同源性LCMV感染期间,抗PD-1/L1治疗后IL-27信号传导是否
在肿瘤中,CD 8 T细胞的扩增/功能至关重要。一旦完成,这些研究将提供重要的
了解IL-27如何调节抗病毒和抗肿瘤反应。此外,这项研究的结果
应该指出可以用来维持最佳T细胞反应的治疗方法和方式。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
B cell-derived IL-27 promotes control of persistent LCMV infection.
- DOI:10.1073/pnas.2116741119
- 发表时间:2022-01-18
- 期刊:
- 影响因子:11.1
- 作者:Pratumchai I;Zak J;Huang Z;Min B;Oldstone MBA;Teijaro JR
- 通讯作者:Teijaro JR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Ross Teijaro其他文献
John Ross Teijaro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Ross Teijaro', 18)}}的其他基金
The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.
IL-27 在维持耗尽的 CD8 T 细胞对持续感染和癌症的反应中的作用。
- 批准号:
10445313 - 财政年份:2021
- 资助金额:
$ 54.82万 - 项目类别:
The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.
IL-27 在维持耗尽的 CD8 T 细胞对持续感染和癌症的反应中的作用。
- 批准号:
10316578 - 财政年份:2021
- 资助金额:
$ 54.82万 - 项目类别:
Engineer Immune Cells via Chemoenzymatic Glycan Editing
通过化学酶聚糖编辑工程免疫细胞
- 批准号:
10350593 - 财政年份:2019
- 资助金额:
$ 54.82万 - 项目类别:
Engineer Immune Cells via Chemoenzymatic Glycan Editing
通过化学酶聚糖编辑工程免疫细胞
- 批准号:
10578671 - 财政年份:2019
- 资助金额:
$ 54.82万 - 项目类别:
IL-27 elicited antibodies: A novel means to control persistent Arenavirus infection
IL-27 引发抗体:控制持续性沙粒病毒感染的新方法
- 批准号:
9204389 - 财政年份:2016
- 资助金额:
$ 54.82万 - 项目类别:
Novel Strategies for Controlling Persistent Viral Infection
控制持续病毒感染的新策略
- 批准号:
9077410 - 财政年份:2016
- 资助金额:
$ 54.82万 - 项目类别:
Novel Strategies for Controlling Persistent Viral Infection
控制持续病毒感染的新策略
- 批准号:
9248857 - 财政年份:2016
- 资助金额:
$ 54.82万 - 项目类别:
The Role of IL-27 in Controlling Persistent Viral Infection
IL-27 在控制持续病毒感染中的作用
- 批准号:
8897666 - 财政年份:2014
- 资助金额:
$ 54.82万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 54.82万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 54.82万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 54.82万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 54.82万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 54.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 54.82万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 54.82万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 54.82万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 54.82万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 54.82万 - 项目类别:
Grant-in-Aid for Early-Career Scientists